Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Hypothalamic-pituitary-adrenal axis hyperactivity is associated with decreased brain-derived neurotrophic factor in female suicide attempters.

Ambrus L, Lindqvist D, Träskman-Bendz L, Westrin Å.

Nord J Psychiatry. 2016 Nov;70(8):575-81. doi: 10.1080/08039488.2016.1184310. Epub 2016 May 23.

PMID:
27216156
2.

HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients.

Jokinen J, Nordström P.

J Affect Disord. 2009 Jul;116(1-2):117-20. doi: 10.1016/j.jad.2008.10.015. Epub 2008 Dec 2.

PMID:
19054569
3.

Increased plasma levels of circulating cell-free mitochondrial DNA in suicide attempters: associations with HPA-axis hyperactivity.

Lindqvist D, Fernström J, Grudet C, Ljunggren L, Träskman-Bendz L, Ohlsson L, Westrin Å.

Transl Psychiatry. 2016 Dec 6;6(12):e971. doi: 10.1038/tp.2016.236.

4.

Leptin, Anxiety Symptoms, and Hypothalamic-Pituitary-Adrenal Axis Activity among Drug-Free, Female Suicide Attempters.

Ambrus L, Westling S.

Neuropsychobiology. 2019;78(3):145-152. doi: 10.1159/000500737. Epub 2019 Jun 12.

PMID:
31189176
5.

Suicidal intent and the HPA-axis characteristics of suicide attempters with major depressive disorder and adjustment disorders.

Lindqvist D, Träskman-Bendz L, Vang F.

Arch Suicide Res. 2008;12(3):197-207. doi: 10.1080/13811110802100775.

PMID:
18576201
6.

CSF 5-HIAA and DST non-suppression -independent biomarkers in suicide attempters?

Jokinen J, Mårtensson B, Nordström AL, Nordström P.

J Affect Disord. 2008 Jan;105(1-3):241-5. Epub 2007 May 17.

PMID:
17499856
7.

Attention-deficit/hyperactivity disorder symptoms and stress-related biomarkers.

Vogel SWN, Bijlenga D, Verduijn J, Bron TI, Beekman ATF, Kooij JJS, Penninx BWJH.

Psychoneuroendocrinology. 2017 May;79:31-39. doi: 10.1016/j.psyneuen.2017.02.009. Epub 2017 Feb 13.

PMID:
28249186
8.

HPA axis dysregulation in men with hypersexual disorder.

Chatzittofis A, Arver S, Öberg K, Hallberg J, Nordström P, Jokinen J.

Psychoneuroendocrinology. 2016 Jan;63:247-53. doi: 10.1016/j.psyneuen.2015.10.002. Epub 2015 Oct 28.

PMID:
26519779
9.

Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour.

Duval F, Mokrani MC, Correa H, Bailey P, Valdebenito M, Monreal J, Crocq MA, Macher JP.

Psychoneuroendocrinology. 2001 Jul;26(5):521-37.

PMID:
11337135
10.

Salivary cortisol and suicidal behavior--a follow-up study.

Lindqvist D, Isaksson A, Träskman-Bendz L, Brundin L.

Psychoneuroendocrinology. 2008 Sep;33(8):1061-8. doi: 10.1016/j.psyneuen.2008.05.012. Epub 2008 Jul 30.

PMID:
18672335
11.

Blunted HPA Axis Activity in Suicide Attempters Compared to those at High Risk for Suicidal Behavior.

Melhem NM, Keilp JG, Porta G, Oquendo MA, Burke A, Stanley B, Cooper TB, Mann JJ, Brent DA.

Neuropsychopharmacology. 2016 May;41(6):1447-56. doi: 10.1038/npp.2015.309. Epub 2015 Oct 9.

12.

HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients.

Jokinen J, Nordström P.

Psychoneuroendocrinology. 2008 Nov;33(10):1387-93. doi: 10.1016/j.psyneuen.2008.07.012. Epub 2008 Sep 20.

PMID:
18805641
13.

[Dysfunction of the hypothalamic-pituitary-adrenal axis in adolescents after a suicide attempt].

Gmitrowicz A, Kołodziej-Maciejewska H.

Psychiatr Pol. 2001 Sep-Oct;35(5):803-18. Polish.

PMID:
11842612
14.

Blunted HPA axis activity prior to suicide attempt and increased inflammation in attempters.

Melhem NM, Munroe S, Marsland A, Gray K, Brent D, Porta G, Douaihy A, Laudenslager ML, DePietro F, Diler R, Driscoll H, Gopalan P.

Psychoneuroendocrinology. 2017 Mar;77:284-294. doi: 10.1016/j.psyneuen.2017.01.001. Epub 2017 Jan 10.

15.

Cortisol reactivity and suicidal behavior: Investigating the role of hypothalamic-pituitary-adrenal axis responses to stress in suicide attempters and ideators.

O'Connor DB, Green JA, Ferguson E, O'Carroll RE, O'Connor RC.

Psychoneuroendocrinology. 2017 Jan;75:183-191. doi: 10.1016/j.psyneuen.2016.10.019. Epub 2016 Oct 24.

16.

Hypothalamic-pituitary-adrenal axis functioning in Huntington's disease and its association with depressive symptoms and suicidality.

Hubers AA, van der Mast RC, Pereira AM, Roos RA, Veen LJ, Cobbaert CM, van Duijn E, Giltay EJ.

J Neuroendocrinol. 2015 Mar;27(3):234-44. doi: 10.1111/jne.12255.

PMID:
25565388
17.

ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide.

Jokinen J, Nordström AL, Nordström P.

J Affect Disord. 2008 Feb;106(1-2):145-52. Epub 2007 Jul 27.

PMID:
17662471
18.

Relationships between psychological distress, coping styles, and HPA axis reactivity in healthy adults.

Hori H, Ozeki Y, Teraishi T, Matsuo J, Kawamoto Y, Kinoshita Y, Suto S, Terada S, Higuchi T, Kunugi H.

J Psychiatr Res. 2010 Oct;44(14):865-73. doi: 10.1016/j.jpsychires.2010.02.007. Epub 2010 Mar 23.

PMID:
20334880
19.

HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients.

Jokinen J, Nordström P.

J Affect Disord. 2009 Jul;116(1-2):88-92. doi: 10.1016/j.jad.2008.10.025. Epub 2008 Dec 2.

PMID:
19054568
20.

Noradrenergic function and HPA axis dysregulation in suicidal behaviour.

Jokinen J, Ouda J, Nordström P.

Psychoneuroendocrinology. 2010 Nov;35(10):1536-42. doi: 10.1016/j.psyneuen.2010.05.008. Epub 2010 Jun 25.

PMID:
20576361

Supplemental Content

Support Center